Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB14702ApprovedSmall molecule
Sodium metavanadate: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Tyrosine-protein phosphatase non-receptor type 1 and Sodium/Potassium Transporting ATPase
- Formula / weight
- NaO3V · 121.9295 g/mol (avg)
- First approval
- Canada, 1998
- Also known as
- Sodium trioxovanadate · Sodium vanadate · Sodium vanadate(V) · Sodium vanadium oxide
Resolves to
Structure
InChIKey
CMZUMMUJMWNLFH-UHFFFAOYSA-NSMILES[Na+].[O-][V](=O)=OWhat you can answer from here — as of August 30, 2026
Which drugs share a target with Sodium metavanadate, and which of those have an active Phase 3 trial?